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INTRODUCTION 
 Ancient  texts in India  mention about the disease  “Madhumeha” which  
corresponds to the  term  “Diabetes mellitus”. It suggests that diabetes should 
have been  in India even before 2500 BC. But  no evidence is available to know 
its  prevalence.(65) 
 Diabetes Mellitus is a chronic metabolic disease present throughout the 
world that leads to increased morbidity and mortality which is major worry for 
the public health care workers. Inspite of vast developments in the treatment of 
Diabetes mellitus there is an increased prevalence and complications of this 
disease.  
 In 2011  366 million people with diabetes were present throughout the 
world and  it is expected to increase to 552 million in 2030.(61) Most of them 
live in low- and middle-income countries like India. 
 These countries are going to have the greatest increase over the next 19 
years. The  ICMR-INDIAB national studypublished that there are  62.4 million 
people with type 2 diabetes and 77 million people with  
pre-diabetes in India. (62)Thesenumbers are expected  to increase to  
101 million by the year 2030.There are few population based studies on 
complications of diabetes in India.(63,64) According to those studies the 
prevalence of diabetic retinopathy was 17.6%, microalbuminuria was 26.9% 
neuropathy was 26.1%, coronary  disease was 21.4% and peripheral artery 
disease  was 6.3%. 
 Cardiovascular disease is a major cause for increased mortality in 
Diabetic patients. The terms Coronary artery disease, Ischemic heart disease are 
synonymous and they point to a single disease coronary heart disease which is 
expected to become the most common cause of death around the world by 2020. 
At present the  South East Asian Countries like India, SriLanka, Pakistan , 
Nepal have an increased incidence of coronary artery disease. 
 Many  Diabetic patients with Coronary  disease may not have  classical 
risk factors otherthan diabetes and even the lipid profile will be normal. This led 
research on newer risk factors for the development of coronary artery disease in 
Diabetes Mellitus. 
 Comprehensive research in this field have brought in newer biomarkers 
and inflammatory markers for coronary artery disease.  
 They are increased LPa levels, elevated plasma Fibrinogen, 
Homocysteine, Plasminogen Activator Inhibitor 1, CRP and Microalbuminuria. 
These risk factors effects are multiplicative rather than additive. People with 
many risk factors are at more risk. So assessment of a person should be holistic 
to identify all the risk factors so that modification of these risk factors if 
possible could alter  the incidence of coronary artery disease. 
 Microalbuminuria is nowadays taken as a risk factor for the Coronary  
disease among Diabetes as well as in Non Diabetes.  
 Microalbuminuria is a marker of endothelial  and vascular damage and  
predicts coronary atherosclerosis. Patients with microalbuminuria have an 
increased mortality rate due to coronary  artery disease. Likewise these patients 
have a more complex and  severe form of coronary lesions on angiography 
when compared to  people without microalbuminuria. Many studies have shown 
the  relationship between microalbuminuria and coronary  disease in diabetic 
patients.  
 Microalbuminuria may be an important indicator of absolute  
cardiovascular risk to the community. Persistent microalbuminuria also leads to 
renal disease which again increases morbidity and  mortality. 
 Even microalbuminuria in non diabetes have an increased  incidence of 
coronary artery disease. 50% of the microalbuminuria patients die due to 
cardiovascular disease even before they reach the stage of end stage renal 
disease. 
 Among the elderly more than 60 years ,microalbuminuria leads to 
coronary artery disease  most frequently than other  established risk factors for 
cardiovascular disease. It reflects the  presence of an already coexistent 
coronary artery disease. 
  A study have shown that microalbuminuria was related to coronary 
artery disease , dyslipidemia, and hypertension. This  indicates that 
microalbuminuria enhances the risk of coronary artery  disease along with other 
risk factors. Microalbuminuria suggests not only the pressure effect onrenal 
vessels but significant  atherosclerotic disorder in the wholevascular system. 
Hence  microalbuminuria may a marker for the underlying vascular disorder 
and not alone suggesting a renal disorder. 
 
  
LITERATURE REVIEW 
 Diabetes mellitus is a major independent risk factor of  coronary 
heartDisease.(4) The increase in coronary heart disease in  diabetes mellitus is 
due tothe accelerated atherosclerosis, which starts at  an early age and advances 
rapidly to major cardiovascular events in  individuals with diabetes than those 
without it.(1) 
 American Diabetes Association criteria in the diagnosis of  Type 2 
diabetes mellitus is(3) 
1. Fasting plasma glucose morethan or equal to 126 mg/dl.  OR 
2. 2 hour plasma glucose more than or equal 200mg/dl after 75 gms 
Glucose tolerance test.  OR 
3. Symptoms of hyperglycemia like polyuria, polyphagia with random 
plasma glucose morethan or equal 200 mg/dl  OR 
4. HbA1c more than or equal to 6.5 % . 
 Patients with diabetes mellitus are also prone for arterial thrombosis due 
to persisting activated thrombogenic pathway and impaired fibrinolysis . This 
combined arterial disease and prothrombotic state is the major reason for acute 
ischemic heart disease in diabetes mellitus. Coronary artery disease in diabetes 
is often diffuse with an  increase in the number of vessels affected. 
 Multivariate analysis with large prospective studies like  Framingham 
study, Multiple Risk Factor Intervention Trial ( MRFIT)(5), Nurse Health Study 
(6) demonstrate that diabetes is associated with  
2-5 fold increase in coronary heart disease and cardiovascular disease  related 
death. Multiple factors like systemic hypertension, insulin  resistance, 
dyslipidemia,  hypercoaggulable state, inflammatory states also contribute for 
the cardiovascular disease in diabetics. 
 Atherosclerosis is a progressive disease of the arterial wall that involves 
inflammation, lipid deposition, remodelling, fibrosis and thrombosis. Initial 
atherosclerotic lesion includes lipid deposits in the form of fatty streaks in the 
intima with increase in the macrophages and foam cells.  
 These early lesions may be insignificant and may regress or develop into 
advanced atherosclerotic complex. (7) Intermediate lesions include atheroma 
which is a focal accumulation of lipid within the neointima along with increased 
foam cells , origin from macrophages and vascular smooth muscle cells , 
leading to the formation of a lipid rich plaque core. These intermediate lesions 
arise from either fatty streaks or pre-existing  intimal cell masses. Fibrous 
plaques are formed as a cap of connective tissue, involving the vascular smooth 
muscle in collagen and proteoglycan matrix that accumulate between the lipid 
core and vessel lumen. Thickness of the fibrous cap and its infiltration with 
macrophages affect the stability of the lipid cap. Thin fibrous cap and increased 
macrophage accumulation are rupture prone atheroma. Fibrotic lesions can also 
develop in lesions that do not have lipid core.(8) 
 The rupture of a plaque fibrous cap depends on the balance between the 
forces that impinge on the cap and the integrity of the fibrous cap.Collagen give 
good integrity for the fibrous cap. Factors leading to disordered metabolism of 
the collagen may impair the ability to repair the plaque leading to its propensity 
to rupture. Increased catabolism of the extracellular matrix and increased matrix 
metalloproteinases from macrophages also lead to weakening of the plaque 
resulting in its rupture. 
 A vulnerable plaque is one that has increased propensity to rupture. 
Characters of such plaque are decreased smooth muscle cells, increased 
accumulation of macrophages and a large lipid pool. Apoptotic macrophages 
and smooth muscle cells can produce tissue factor which can lead to thrombosis 
on plaque rupture.(8) 
 Cardiac disease is the major cause for morbidity and mortality in diabetic 
patients. ( 9)This is most likely due to the macrovasculardisease  secondary to 
atherosclerosis. But mechanism of coronary artery disease in some diabetics 
have similarities likethose in the kidneys, nephropathy ( microvascular disease). 
 The problem of macrovascular disease is more pronounced in type 2 
diabetes rather than type I diabetes . The American Heart Association has made 
diabetes  a major risk factor for cardiac and vascular disease .Multiple risk 
factors have been found to contribute to macrovascular disease in diabetes. This 
has been proved in the United Kingdom Prospective Diabetes Study ( 
UKPDS)(11) . Biochemical mechanisms secondary to the metabolites of 
glucose affect a number of cellular pathways both intra and extra cellularly 
leading to adverse effect on the vascular walls. The mechanisms are (2) 
1. Increase in non enzymaticglycation of proteins 
 These glycated products can act on inflammatory agents torelease 
cytokines or directly lead to vascular dysfunction.  Collagen present throughout 
the body has lysine which has a long biological life and its glycation leads to 
advanced glycationendproduct(AGE) .  These AGE on the wall of vessel lead to 
excess trapping of LDL cholesterol and its oxidation.  There is a correlation 
between the degree of glycemia and the macrovascular disease. 
Activation of Polyol  pathway. 
 Excess glucose enter the vascular endothelial cells and get converted into 
sorbitol. Excess sorbitol leads to change in redox potential or alter the signal 
transduction pathway ie activation of Diacylglyceraol and Protein kinace C. 
These changes affect the permeability, angiogenesis, cytokine activation and 
leucocyte adhesion of the vascular endothelial cells. 
Activation of Protein kinase C and Diacyl glycerol cascade. 
 Diacyglycerol present in cells are the activators of Protein kinase C.Diacy 
glycerol is derived from hydrolysis of phosphotidylinositides or denovo 
synthesis. Persistent hyperglycemia increases the levels of PKC and DAG  in 
tissues likeheart, aorta, retina, glomeruli and liver. Such increase requires 
persistently elevated hyperglycemia for atleast five days. This elevated DAG 
PKC cascade leads to a number of intracellular and functional abnormalities in 
vascular cells. It results in increased release of arachidonic acid and 
prostaglandin E2 as a result of which there is decreased sodium potassium 
ATPase activity which inturn affects the cellular integrity, growth and 
differentiation. PKC increased levels can lead to increased transforming growth 
factor beta which increases Type IV and Type VI collagen and fibronectins that 
suppress the proteoglycans in extracellular matrix. Less proteoglycans leads to 
less lipoprotein lipase and consequent poor clearance of VLDL. These leads to 
typical dyslipidemia in diabetics . Increased Type IV collagen results in 
expansion of  basement membrane leading to vascular dysfunction. 
Oxidative stress  
 Nonenzymaticglycation is a process that affects proteins like structural 
proteins, coagulation proteins, lipoproteins or carrier proteins in circulation. 
Persistent hyperglycemia produces oxygen free radicals and contributes to 
increased Advanced Glycation Products (AGP). This increases the oxidative 
stress in diabetics. This increase in oxidative stress as manifested by increased 
NADH/ NAD ratio in various cells, also leading to decreased nitrous oxide 
production in vascular endothelium. 
 In the vessel they result in depressed LPL activity, decreased insulin 
action, attenuated fibrinolysis, increased von willibrand factor , defective 
production of endothelial derived relaxation factor, and  increased oxidised 
LDL. Increased oxidised apoB100 in diabetics  mediates excess of receptor 
uptake of LDL by endothelial cells.  
 This oxidised LDL molecule is well recognised by the macrophage 
scavenger receptors , taken up by them and form foam cells inatheromatous 
lesions. Within the foam cells the degradation of LDL is impaired resulting in 
further accumulation of Oxidised LDL.Oxidised LDL increases the adhesion of 
circulating macrophages to the damaged endotheliumin creasing their migration 
into the intima. Oxidised LDL is more immunogenic stimulates foam cell 
formation and platelet  aggregation. Oxidised LDL increases the affinity for 
glucose links which in turn increases the oxidative stress on the tissues. 
 Insulin in physiological levels haveantiatherogenic actions but in insulin 
resistantce states resulting in hyperinsulinemia it leads to  atherosclerosis.(10) 
At physiological levels insulin leads to increased nitrousoxide levels , retards 
migration and growth of smooth muscle cells from subendotheliallayervof 
vascular wall. In hyperinsulenemic states the vascular wall responds to the 
mediators and mechanisms rather than to the insulin.Hyperinsulinemia leads to 
a state of enhancedatherosclerosis through the following mechanisms.  
 Increased secretion and expression of plasminogen activator inhibitor 1 
by endothelial cells and hepatocytes. As PAI 1 is a inhibitor of fibrinolysis, its 
increase results in increased thrombosis and vascular occlusion. Increased levels 
of vonwillebrand factor and other procoggulant proteins are increased. 
Increased levels of fibrinogen  which is an acute phase reactant suggest role of 
acute phase reactants in hyperisulinemia and accelerated atherosclerosis.   
 Two prospective studies Quebec Cardiovascular Study and British 
Regional Heart Study revealed that there is a threshold for the macrovascular 
disease enhancing effect of insulin and an increase in one standard deviation in 
insulin level increases the cardiovascular risk by 70%. 
 Abnormal rheology also contributes to accelerated atherosclerosis.(2) 
This results in increased plasminogen activator  inhibitor1 , von willibrand 
factor, fibrinogen factors VII, VIII, thrombin antithrombin III , protein C,S 
which have natural antithrombogenic activity are reduced in quantity. 
 Microvascular complication of diabetes is a major health concern.(12) 
Four main hypothesis have been postulated for the development of 
microvascular complications. They are increased polyol pathway flux, increased 
advanced glycation products, activation of protein kinase C, and increased 
hexoxasamine pathway flux. microvascular change leads to various 
pathophysiological processes in retina, kidney, neurons, basement thickening, 
increased vascular permeability, and neovascularisation. 
 Diabetic nephropathy  ,a common microvascular disorder of both type1 
and type2 diabetes mellitus. It is defined as theoccurence of permanent 
proteinuria in a diabetic patient usually with retinopathy, elevated blood 
pressure and declining glomerular function in the absence of urinary tract 
infection and other renal diseases producing proteinuria and cardiac failure(13).  
 The incidence of nephropathy in type I diabetes mellitus is  30% and in 
type 2 diabetes is 20%. But it is commoner to see more number of nephropathy 
in type 2 diabetes mellitus than in type I due to the increased prevelence of type 
2 diabetes. Initially it was thought that renal failure is less common with type 2 
diabetes. But nowadays due to better treatment modalities for hypertension and 
coronary heart disease it is now possible to increase the lifespan of diabetic 
people sothat we are seeing more number of chronic kidney disease patients 
among  type 2 diabetes mellitus.(12) 
 Microalbuminuria has been widely accepted as an important marker of 
diabetic renal disease as well as of early vascular complications. Diabetic 
kidney disease is defined as the presence of  dipstick positive proteinuria. 
Microalbiminuria predicts the development  of future diabetic renal disease. 
Further it is associated strongly with cardiovascular risk and coronary heart 
disease in diabetes.(15) 
 
Condition 24 hr albumin 
excretion 
Overnight 
urinary 
albumin 
excretion rate
Albumin 
creatinine 
ratio 
Macroalbuminuria >300mcg/day >200 
mcg/min 
>0.2 
Microalbuminuria 30- 300 
mcg/day 
20-
200mcg/min 
0.02-0.2 
Normoalbuminuria <30mcg/day <20mcg/min <0.01 
 
 
 Timed urinary collections 24 hr or overnight remain the gold  standard for 
quantificationof proteinuria. But they are cumbersome for the patients. The use 
of albumin creatinine ratio in the early morning sample is a convenient and 
reliable method.(16) Several factors like urinarytract infection, menstruation, 
exercise, fever can give a false positive result. 
 
 The natural history of renal involvement is well defined in type  
1 diabetes. The diagnosis of diabetic nephropathy is based on clinical evidence. 
In the typical course the development of proteinuria is slow.  
 Initially it is intermittent , then becoming persistent and increasing. The 
onset of proteinuria is associated with hypertension and declining glomerular 
function. Usually diabetic retinopathy is associated with diabetic nephropathy. 
In type 2 diabetes mellitus especially those who do not have diabetic 
retinopathy 25% of them will be having other renal diseases producing the 
proteinuria.  Both type 1 and type2 diabetes are at risk for developing 
nephropathy. But only type 1 diabetic has increased risk of progression to end 
stage renal disease. But due to the increased number of type 2 diabetes there is 
an increased incidence of chronic renal disease in type2 diabetes.  
Stages of kidney involvement in diabetes.(15) 
Stage 1   glomerular hypertrophy and hyperfiltration 
Stage 2   silent stage ; normal albuminuria but glomerular lesion   
 Present on histology. 
Stage3 microalbuminuria 
Stage 4   overt diabetic nephropathy and clinical proteinuria 
Stage 5   end stage renal failure. 
 During the silent phase there is an increased glomerular  filtration rate 
which is increased to about 20% to 40% and is evident in both type  
1 and type 2 diabetes mellitus. (17)Hyperfiltration depends on  thelevel of 
glucose control. Good glycemic control can bring back the urine albumin level 
to normal values. 
 Epidemiological and other data have shown that microalbuminuria  
results in raised all cause  cardiac mortality, cardiac abnormalities, 
cerebrovascular diseases, and peripheral vascular disease.  
 Adverse clinical outcomes in cardiovascular disease have been observed  
even at values lesser than that for microalbuminuria. (18, 19) the  
correlationbetween the mortality and microvascular disease is in studies  
involvinghigh risk patients. In the Heart Outcomes Prevention Evaluation 
(HOPE) study presence of microalbuminuria  increased the cardiovascular risk . 
The mortality due to all cause in patients with micoalbuminuria was 18.2% and 
in those without normal albuminuria was 9.4%. A linear relationship was seen 
among  themicroalbuminuria patients for cardiovascular events, with values 
well below the routine  urine microalbumin levels. 
 In another prospective study with individuals between 50 to 75 yrs, 
presence ofmicroalbuminuria  increased the risk for  CV deaths.(20)The 
mortality for all cause was more inpatients with microalbuminuria, especially in 
patients with coexisting hypertension. 
 The  mortality due to all cause can be predicted in the general population 
in presence of microalbuminuria.(22) This information is seen in the Prevention 
of Renal and Vascular Endstage Disease (PREVEND) Study.(21)In that study , 
people of Groningen, Netherlands, aged between28 to 75 yrs had a 
questionnaire and a bottle to collect an  
early-morning urine sample for Urine Albumin Excretion measurement.40,548 
peoplewere followed for 2.6 yrs. A positive relationship was seen between 
Urine Albumin Excretion and all-cause, CV, andnoncardiovasculardeath. 
Thisrelationship was seen at levels of albuminuria that was consideredto be 
normal. 
 Prospective and epidemiological studies have shown that 
microalbuminuria is an independent and seperate among the routine risk factors 
of all cause and cardiac and vascular mortality and  cerebrovascular events in 
people with diabetes mellitus or hypertension  in the general population. 
National Health and Nutrition Examination survey states that 8.8% US adults 
have microalbuminuria. Elderly, femalesexand non Hispanics were seen to be 
associated with increased incidence of Microalbuminuria in presence of 
diabetes mellitus and hypertension. This prevalence increases with increased 
duration of the  disease. 
 Microalbuminuria is associated with a number of cardiac  disorders and 
diseases like left ventricle hypertrophy, coronary diseases etc. (24)  The Strong 
Heart Study had shown a significant relationship between microalbuminuria and 
left ventricle diastolic and systolic dysfunction.(25) The Losartan Intervention 
for Endpoint reduction in Hypertension Study LIFE  confirmed that there is an 
association between the microalbuminuria and echo evidence of  increased Left 
ventricle mass and hypertrophy among untreated  hypertension patients.(26) 
Another study have shown that there is  increased evidence for ischemic heart 
disease as seen in stress echo, stress ECG in the people withmicroalbuminuria 
when compared to normal albuminuria.(27) The PREVEND study  showed an 
independent relationship between microalbuminuria and infarct patterns, major 
and minor ischemia.(28) Further it also identified that the group which had 
microalbuminuria had a higher cardiovascular mortality than the other groups.In 
another study which was an population based study conducted by Borch 
Johnson et all showed that 2.3 fold increased relative risk of ischemic heart 
disease among people with microalbuminuria even without renal disease or 
diabetes. This study also showed that the survival free from ischemic heart 
disease is 97% among normal albumin excreting individuals compared to 
microalbuminuric individuals who had a survival free period from IHD being 
91%. The coronary artery risk associated with other risk factors almost doubled 
when associated with microalbuminuria.(29) 
 An angiographic study conducted by  Tuttle et all showed a positive 
correlation between increased urinary albumin excretion angiographic evidence 
of coronary heart disease. (23)It also showed that these people with excess 
urinary albumin excretion had more severe coronary artery disease as evidenced 
as seen by coronary angiography. 
 The pathophysiology underlying the link between microalbuminuria and 
coronary artery disease and other cardiovascular diseases are not clear. 
Microalbuminuria can be a cause of vascular disease or complication of a 
vascular disease. According to the STENO hypothesiskidneys are the window 
of vascular system.(31) Hence urinaryalbumin leakage is an expression of 
vascular damage. So endothelialdysfunction and chronic inflammation are 
considered as probable underlying causes to associate microalbuminuria with  
cardiovascularevents.(32)But there are inconsistencies in this theory. 
  
 Less grade inflammation may lead to endothelial dysfunction and 
inflammatory markers have been identified to mark the presence of chronic 
inflammation in atherosclerosis. Some other studies show that 
microalbuminuria, chronic inflammation , endothelial dysfunction are linked 
and they are independent risk factors for cardiovascular death. 
 Many cross sectional studies have shown that increase urine albumin 
excretion  islinked with many cardiovascular risk factors like increased age, 
male sex, systemic hypertension, diabetes mellitus , smoking, increased body 
weight and dyslipidemia. Strategies that are associated with reduction of urinary 
albumin excretion is said to be cardioprotective as shown in the study conducted 
by Ibsen et all.(31)- smaller clinical trials have shown the advantage of limiting 
the progression of microalbuminuria to macroalbuminuria. But whether this 
advantage could translate to lessened cardiovascular events is not known. In the 
trials like Irbesartan Diabetic Nephropathy Trial IDNT and Reduction of 
Endpoints in NIDDM with Angiotensin II Antagonist Losartan RENAAL have 
shown  therapeutic strategies that reduce proteinuria leads to decreased 
cardiovascular events but less is known whether this reduction can be 
extrapolated to microalbuminuric patients. 
 
 Another theory is that certain individuals have inherently variable levels 
of vessel function even within their physiologic range and hence can have 
varying degrees of microalbuminuria. This inherent  vascular ability can lead to  
subsequent end organ damage.(32) 
 Intensification of blood pressure control, glucose control and better LDL 
cholesterol control , can  normalise the albuminuria which represents a 
biomeasure of treatment success. 
 The National Kidney Foundation guidelines say that microalbuminuria 
screening  to be done in patients with diabetes mellitus, systemic hypertension , 
family history of endstage kidney disease, elderly more than sixty years(34) . 
The American Diabetes Association says that  urine albumin level  screening to 
be done once in every five years in type I diabetes and in type 2 diabetes when 
during diagnosis.(35A dipstick is a semiquantitative and insensitive method  
anddetects albumin more than 300 mg/day. Many antibody based  technique are 
present to quantify urine albumin excretion less than 300 mgperday. They 
include Radioimmunoassay ,Nephelometry, immunotebidometry and Enzyme 
linked immunosorbent assay. A more  modern HPLC method has been devised 
to detect microalbuminuria (33). sensitive methods to identify albumin 
excretion at an earlier stage are required to prevent the increased cardiovascular 
risk.  
 These methods vary in their sensitivity and measurement times as 
Follows.(36 – 38) 
Method  Time for assay 
Single radial 
immunodiffusion 
Mancini et al 1 day 
Electroimmuno assay Laurel 1966  4-6 hours 
Immunoturbidometric 
assay 
Teppo 1982 20-30 minutes 
RIA Keen 1963 1-2 days 
ELISA Fielding 1983 5-6 hours 
Zone 
immunoelectrophoresis 
Vesterberg 16- 18 hours 
Fluorescent 
immunoassay 
Charves 1984 4-6 hours 
immunonephalometry Vasquez 1984 6 hours 
 
 The albumin creatinine ratio using a overnight sample or first morning 
void sample may be used as a screening procedure for 
detectingmicroalbuminuric patients. But correction to creatine production 
among the gender should be used.+- Classification of Urine Albumin Excretion 
(16) 
 
 
 24 hr 
albumin  
mg / 
day 
Overnight 
Urine 
Albumin 
(mcg/ 
24 h) 
Spot 
urine 
Albumin 
(mg/L) 
Spot urine 
Albumin/Creatinine 
Ratio mg/g 
Normal  < 15 < 10 < 10 Male < 10 
Female < 15 
High normal 15 - < 
30 
10 - 20 10 -20 Male 10 – 20 
Female 15 - 30 
Microalbuminuria 30 – 
300 
20 - 200 20 - 200 Male 20 – 200 
Female 30 – 300 
Macroalbuminuria >300 > 200 > 200 Male > 200 
Female > 300 
 
 Coronary artery angiography is an investigation for the study of cardiac 
arteryanatomy. It was usually assessed as a one , two or three vessel  
diseaseaccording to thethe number of vessels involved and on the amount of 
stenosis the lesion is producing as 50%, 70% 90% 99% stenosis which was 
categorised by Oberman et al in 1972(39). This type  of categorisation gives an 
idea of the anatomical stenosis and its  hemodynamic significance.  But various 
scoring systems were used in different studies to quantify the lesions in the 
coronary artery.  The various scoring systems utilised for coronary artery 
anatomy are as follows : 
 
 Parker et al in 1966 categorised the coronary angiographic severity and 
correlated with  prior Myocardial infarction , prior  symptoms and resting ECG 
changes.(40) 
 Oberman et al in 1972 established the correlation of coronary severity to 
subsequent mortality. 
 Gould et al made animal studies to correlate the percentage of coronary 
stenosis to the amount of coronary blood flow reduction.(43)  
Gensini Score  
 The Gensini score was devised by Gensini(44). It  takes into 
consideration the severity of lesions,  multiple obstructions, and The amount of 
myocardium under risk.A  score is given to every lesion based on  the amount  
of lumen diameter. A multiplier is given to each lesion  depending  on lesion  
location in the coronary tree that in turn  depends on the  significance of the area 
supplied by that segment.  It also considers the collateral factor and  
vesselsuitability for revascularisation. The final  score is the total of the lesion 
scores. 
 Kalbfleisch et al in 1977 made a landmark pathologic study to determine 
the amount of myocardium supplied by each coronary vessel and categorised 
the heart into their vascular type , left coronary type,  right coronary type , 
normal types .(45) 
Coronary Artery Surgery Study Score 
 The Coronary Artery Surgery Study (CASS) score was done by Ringqvist 
et al.The  major three coronary vessels with  more than 70% stenosis is 1 point; 
stenosis of more than 50% in the left main coronary artery is taken as a 2-vessel 
disease and given 2 points. The total score is the sum of all points and is similar 
to one, two-, or three-vessel disease in the coronary tree.  
Duke Jeopardy Score 
 The Duke Jeopardy Score was usedby Dash et al[47] and improved by 
Califf et al(50). The coronary artery anatomy is divided into six segments: the 
Left Anterior Descending , diagonal branches of the LAD, septal perforating 
branches, thecircumflex artery, obtuse marginal artery, and the posterior 
descending artery. Each segment with  ≥70% stenosis is given 2 points. The 
maximum possible points is 12. 
Duke Coronary Artery Disease Severity Index 
 The Duke Coronary Artery Disease Severity Index was used  by Mark et 
al. The score ranges from 0 to 100 with higher  weightage  given to  number of 
involved vessels and severity of LAD stenosis. The  more proximal the disease  
higher is the weightage. 
Friesinger Score 
 The Friesinger Score was developed by Friesinger in 1970[41]. It tries  to 
correlate the anatomical severity to outcome .The score is between 0 to 5.  High 
scores indicate increased severity. 
Sullivan Scores 
 The Sullivan Scores has three scoring systems developed by Sullivan et 
al[49]. It tries to apply the different aspects of atherosclerotic burden. The  score 
is from 0 to 3 and represents the number of vessels with  more than 70% 
stenosis; left main stenosis is considered  as a  one vessel disease. The Lesion 
score similar to Gensini score. The Extent score is the proportion of each vessel 
involvement  by  the atherosclerotic plaque, seen as luminal irregularity, and 
multiplied by a factor  that represents the vessel's  functional significance. The 
total score is out of 100. It  represents the  percentage of atherosclerotic plaque 
on the coronary intimal surface.  
  
Jenkins Score 
 In the Jenkins score[46]  the coronary  artery anatomy is divided  into 
eight  segments and a score is given to each segment depending  on the degree 
of stenosis in  that segment. The points for each lesion are totalled to get the 
finalscore . It  reflects the extent and severity of disease in the proximal 
coronary vessels. 
 Leamann et al in1981 designed a scoring system that takes into account 
lesion severity and amount of myoacardium at risk. It grades the lesion stenosis 
and the Left ventricle weightage factor depending on the amount of blood flow 
to that part of ventricle from that vessel.(48) 
SYNTAX score (51) 
 The SYNTAX (SYNergy  between PCI with TAXUS and Cardiac 
Surgery) study is a  study done to assess the revascularisation strategy needed in 
multivessel disease. The scoring system used in this study is the SYNTAX 
score. It utilises scores such as ACC/AHA coronary segment classification, 
ACC/AHA lesion classification, Leamann sore, DUKE/ICPS bifurcation 
classification system, total occlusion classification system and experts opinions. 
It is a computer designed tool. scores are assigned based on the dominance of 
left or  right coronary artery, number and site of the lesion, presence of total 
occlusion, its characteristics , bifurcation lesion its characteristics,  trifurcation 
lesion, its characteristics, associated aortoostial lesion, tortuosity, calcification, 
thrombus and diffuse disease. 
SYNTAX score calculation 
1.  Dominance of the coronary artery 
2.  Number of lesions in the coronary segments 
3.  Number of segments involved per lesion 
  Lesion characters 
4. Total  coronary occlusion    
Number of segments involved with coronary total occlusion 
total occlusion > 3 months 
Blunt stump of the occlusion 
Bridging collaterals near the occlusion 
First segment beyond occlusion seen due to collaterals 
Side branch involved or not 
 
5. Trifurcation lesion – number of segments with trifurcation. 
 
6. Bifurcation lesion as classified by Dukes and ICPS classification 
Type  
Angulation  less or more than 70 degrees 
 
7. Aortoostialdisease  
 
8. Severe tortuosity one or more bends more than 90 degrees or three or 
more bends  between 45 – 90 degrees. 
 
9. Length of lesion  more than 20 mm 
 
10. Multiple persistent calcification 
 
11. Thrombus containing lesion 
 
12. Diffuse disease/ small vessels 
Number of segments with small vessels. 
 The SYNTAX score was  developed to prospectively assess the coronary 
vessels with respect to the number of lesions and their functional significance, 
site of lesion, and  its complexity. 
 Higher the SYNTAX scores, more complex is the coronary lesion. 
 The coronary tree segments were defined  based on the classification of 
the American Heart Association (48) and which was modified for the ARTS I 
and IITrials (52).  In  this classification the coronary artery is divided into 16 
segments and  has been used as such in the SYNTAX score. 
  
 The 'Leaman score' is based on  severity of luminal  narrowing and 
weighed according to the  blood flow to the leftventricle in each vessel or vessel 
segment. A right dominant system means, the right  coronary artery (RCA) is 
supplying approximately 16%and the left coronary artery (LCA)  is supplying 
84% of the flow to the left ventricle (LV). This 84% is contributed as 66%  
bythe left anterior descending artery (LAD), and as 33% by the left circumflex 
coronary artery (LCX). Therefore , the Left Main artery (LMCA) supplies 
approximately 5 times, the LAD approximately 3.5 times  and the circumflex 
1.5 times of  blood  to the left ventricle. In a left dominant system the Right 
Coronary Artery does not contribute to the bloodsupply of the left ventricle. 
Thus the LMCA supplies 100% blood  to the LV. The RCA contribution of 
blood to the LV is now supplied by the LCX. Therefore  the LAD supplies 58% 
(weighing factor 3.5) and the LCX 42% (weighing factor 2.5) of the total blood 
flow to the LV. Using this principle of relative blood supply to the LV ,the 
coronary segments are given a weighing factor according to their functional 
significance. The contribution by the coronary segment to the amount of blood 
flow to the LV is used as a multiplication factor for the calculation of the 
Leaman score and used as such in the SYNTAX score calculation. 
Score calculation. 
 A lesion is defined as significant if it produces>50% decrease in luminal 
diameter of vessels more than 1.5 mm size by visual assessment.  Less severe 
lesions< 50% are not included in the SYNTAX score calculation. 
 Total  occlusive disease (100% diameter stenosis) and non occlusive (50-
99% diameter stenosis) disease are made out.  The lesion is  multiplied by 2  for 
non-occlusive lesions and  by 5 for occlusive lesions. All  otheradverse lesions 
in the coronary artery segments have additive value. 
  
Segment weighing factors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adverse lesions scoring system 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Lesions less than three vessel diameter reference  (tandem lesion) are 
taken as single lesion. But if multiple lesion separated by more than three vessel 
diameter reference taken as separate lesions. 
 Total occlusion is when no antegrade flow is visible distally or filled by 
bridging collaterals. 
 Bifurcation lesion is lesion at junction of a main vessel and a side branch 
with a diameter more than 1.5mm. 
 Trifurcation lesion are lesions at junction of  one main vessel and two 
side  branches more than 1.5 mm diameter. 
 Small vessels means when more than 75% of the segment distal to the 
lesion is less than 2 mm in diameter. 
 Thrombus  ovoid irregular intraluminal filling defect or translucency  
surrounded on three sides by contrast present distal to or within a lesion in 
multiple views. 
 The syntax score calculator is a computer program that calculates the 
score based on certain sequential interactive questions. 
 
 
 
 Bifurcation lesion classification  Type A,B,C,D,E,F,G. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 OBJECTIVE AND AIM OF THE STUDY 
 
 To stratify the coronary angiographic characteristics in Type2  
 Diabetes Mellitus patients with Microalbuminuria suspected of  having  
Ischemic Heart Disease. 
 
 
 
  
MATERIALS AND METHODS 
 This is a cross sectional prospective study done during the  period 
between December 2013 to febraury 2014. Consecutive diabetes  mellitus type 
2 patients who were suspected of ischemic heart disease but with no  history of 
myocardial infarction who under went coronary  angiography  at the department 
of cardiology Rajiv Gandhi Government  General Hospital, Chennai during this 
period were selected for the study. 
 All patients were diagnosed to have diabetes mellitus according to WHO 
criteria. Inclusion criteria was the same as above with consecutive diabetic 
patients suspected of coronary artery disease undergoing coronary angiography 
during the period between December  
2013 – febraury 2014. 
Exclusion criteria 
1. Not willing for angiography. 
2. h/o underlying renal disease 
3. elevated serum creatinine > 2mg/dl 
4. h/o active urinary tract infection  
 
 
5. h/o malignancy. 
6. h/o prior myocardial infarction / heart failure 
7. h/o macroalbuminuria 
 Clinical characteristics of the patients were recorded. Patient’s age,  sex 
,body mass index , systemic systolic and  systemic diastolic blood pressure , 
smoking status , h/o hypertension, vital signs with routine cardiac clinical 
evaluation were done. Blood pressure was measured with a standard  
sphygmomanometer having mercury at rest. Systemic hypertension was defined 
as  blood pressure more than 140 mmHg / 90  mmHg or have been using 
antihypertensive  drugs. 
Measurement of microalbuminuria:  
 Overnight or early morning urine samples were obtained for 
measurement of urine albumin creatinine ratio. It was  done as a single spot 
specimen.  
 Diagnostic kit  was used to quantify urine creatinine (Jaffe technique) and 
albumin was checked by Bromocresol green method. The apparatus used in the 
evaluation was Alcyon, 3001 and autoanalyser system. 
 
Lab tests:  
 Blood  was collected  12 hours after fasting. It was sent for measurement 
of Blood Sugar, Lipid levels includes Total Cholesterol, Serum Triglycerides, 
Serum LDL, HDL  and serum Creatinine.  
Coronary angiography 
 Coronary angiography was done by a cardiologist with the Thoshiba 
system. Modified Seldingers technique was used when right femoral artery was 
used as the route and Seldingers technique was  used for the radial artery route. 
Various catheters were used depending on the aortic size, route of procedure . 
Local anesthesia with 2% xylocaine was used for the procedure. Pressure of the 
aorta was noted during the catheterisation.  
 Various views were taken to get a good analysis of the lesions in the 
coronary arteries. Selective left and right coronary angiograms were done. 
Heparin 2500 units for femoral route and 5000 units for the radial route was 
used. All the images were recorded and analysis was made. Syntax score 
analysis was made using the online syntax score calculator.  
 
 Statistical analysis was made with Microsoft Excel 2010 by using QI  
Macros software. Data were analysed in terms of average, standard deviation 
for quantitative variables. Comparison of groups was done  with Chi square test 
. Value less than 0.05 was taken as  statistically significant for the P value. 
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 The  age among the normoalbuminuria group  ranged between  
44 years and 72 years and the average age  59.4 years. 
 Standard deviation 6.81; P value  more than 0.05 which was not 
statistically  significant.  
 The age among the microalbuminuriaranged between 51 years and  72 
years and the  average age  60.4 years . standard deviation 2.42; Pvalue more 
than 0.5 was not  statisticallysignificant. 
 But comparing the two groups showed a statistical significance with a P 
value <0.04 and a standard deviation of 0.707. 
 The age distribution among the study population is as follows: 
Age Normoalbuminuria 
N = 61 
% Microalbuminuria 
N= 16 
% 
41-50 yrs 6 7% 0  
51-60 yrs 
 
27 35% 6 7% 
61- 70 yrs 26 33% 10 13% 
>70yrs 2 2% 0  
 
 
 
 
Histogram showing age distribution of the study group. 
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two values using the paired T test for means showed statistical significance with 
a P value of 0.025 (< 0.05). 
 The LDL Cholesterol in the normoalbuminuric group ranged between 
122 – 172 mg/dl and the mean value  148.93 mg/dl ;  among the 
microalbuminuric group it was between 144 – 174 mg/dl and the mean value  
157.75 mg/dl. Comparing the two average didnot show any statistical 
significance P  value more than  0.5.  
 The triglycerides in the normoalbuminuric group ranged between 142 -
210 mg/dl and the mean value  161.39 mg/dl ; in the microalbuminuric group it 
ranged between 146 – 210mg/dl and the average value  165.62 mg/dl. 
Comparing the two values did notshow any statistical significance P value was 
0.5. 
 There were no smokers among the female group in the study population. 
But among men in the normoalbuminuria group 30 out of 61 patients (49%) 
were smokers either currently smoking or had been reformed smokers. Among 
the microalbuminuriagroup 8 out of the  
16 patients were smokers.  
SMOKERS IN STUDY GROUP. 
 C
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 In the normoalbuminuria group 10 patients had Syntax  score  less than 
22 and no patient in the microalbuminuria group had  this score. 
 26 patients of the normoalbuminuria group and 4 patients of the 
microalbuminuria group had a syntax score of intermediate severity between 22 
– 32. 
 Among the normoalbuminuria, 19 patients and in the microalbuminuria , 
12 patients had syntax score > 32 signifying severe lesion. 
 
 
 
 
Syntax score Normoalbuminuria 
N=61 
Microalbuminuria 
N =16 
< 22  10  (16%) 0 
22- 32 26  (42%) 4   (25%) 
>32 19    (31%) 12   (75%) 
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 Among them the 7 smokers and 5 of the non smokers had a syntax score 
of more than 32. 
 Remaining 5 nonsmokers had a syntax score of less than 32. 
 This comparison was statistically significant with a chisquare 4.14 and a 
P value of 0.04. 
 It shows that among the microalbuminuric patients the smokers had 
severe  and complex coronary lesions. 
  
smokers and CAD in the study group. 
Syntax score Normoalbumin microalbumin 
22 - 32         7           0 
>32       16           7 
 
 In this study , in the microalbuminuria group 5 patients had thin vessels 
with diffuse disease with vessels not suitable for CABG and  
4 patients with normoalbuminuria had thin vessels . this difference was 
statistically significant. 
Chi square 5.16 ; P value 0.02. 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 In this study the microalbuminuria was higher in men than in women 
which was significant. This finding correlated with the other studiesdone by 
Guo et al.(54) and Luo et al.(55) and Amir farhang et  al.(53). 
 In this study increased aging was associated with microalbuminuria and 
severe coronary  disease as calculated by syntax score. This was in consistency  
with the other studies done by  El Sherif et al. (56) and Guo et al and Amir 
farhang et al where elderly people were associated with severe coronary artery 
disease. 
 In this study there was a significant correlation between severity of 
coronary artery disease and smoking . This was incorrelation with previous 
studies of Gou et al and Luo et al. Nakaishi Ret al but differed with Amir 
farhang et al. 
 Smoking leads to platelet dysfunction , alteration of antithrombotic and 
prothrombotic factors , alteration in the tissue factor and tissue factor pathway 
inhibitor – 1 leading to increased thrombogenic potential. Further there is 
decreased release of tPA which leads to reduced natural fibrinolysis. The  
oxidativestress due to free radicals is an important step in development of 
atherosclerosis. (59) The interreaction between free radicals like superoxide and 
the nitrous oxide , decreases nitrous oxide but also produces peroxy nitrite that 
further rises the  oxidative stress in the cells.  Elevated oxidative stressand  
decrease of nitrous oxide leads to proatherogenicity and prothrombotic state. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Potential pathways and mechanisms of smoking related cardiovascular 
diseases. The bold boxes signify the main mechanisms. 
 The severity of coronary disease and microalbuminuriadid  not find any 
relationship to HDL Cholesterol levels, LDL Cholesterol levels, systemic 
Systolic Blood Pressure and Diastolic Blood Pressure and Body Mass Index . 
This observation in this study differed with the previous studies of Guo et al and 
Luo et al but correlated with that of Amir farhang et al.  This difference could 
be due to the  smaller sample size, ethnicity, drugs ,and geographical factors. 
 In this study there was a statistical significant  correlation 
betweenmicroalbuminuria and the severity of coronary artery disease.  
12  patients of the microalbuminuria group had a syntax score of more than 32 
signifying severe coronary artery disease which had a statistically significance. 
This was in correlation with otherstudies of Devici et al(58) , Sukhija et al (57), 
Sherif et al(56), Guo et al, Amir farhang et al. 
 The pathological changes that occur in microalbuminuria and in 
premature atherosclerosis is almost the same. Decreased heparin sulphate in the 
endothelial cells of the vasculature leads to reduced Lipoprotein Lipase which 
in turn causes decreased clearance of VLDL and leads to dyslipidemia. 
Dysfunction of endothelial and less grade inflammation are more common in 
people with microalbuminuria.(60) 
 This study also shows a significant correlation of microalbuminuria with 
intermediate severity of coronary artery disease. There is a statistically 
significant finding that coronary  lesions with intermediate severity with syntax 
score between 22 – 32  were associated with the microalbuminuria group.  
 This study also shows that patients with microalbuminuria had a 
statistically significant result in having thin vessels with diffuse disease; vessels 
being not suitable for CABG. 
 
 
 
 
  
CONCLUSION 
 The following conclusions are made from this study. 
1. IN Type 2 Diabetes mellitus presence of micoalbuminuria predicts a severe 
form of coronary  disease with complex and severe coronary lesions. 
 
2. Elderly  with Type2 Diabetes Mellitus with microalbuminuria have severe 
form of coronary disease. 
 
3. There were increased males having microalbuminuria than females. 
 
4. The smokers with diabetes had an increased severity of coronary  
 Artery disease and especially  in the  patients with microalbuminuria. 
 
5. People with microalbuminuria had significant diffuse disease with thin 
vessels unsuitable for revascularisation. 
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STRATIFICATION OF CORONARY  
ARTERY MORPHOLOGY IN  
DIABETIC CAD  PATIENTS WITH 
MICROALBUMINURIA 
Aims and  
Objective 
To analyse  the clinical characters and 
coronary 
 anatomy by angiography among diabetics 
with and without  
microalbuminuria 
Design of the study duration of study Prospective observational study 
Ethical clearance Applied  
Consent  An informed consent will be obtained from 
all the patients 
Material/ selection of subjects  Diabetic patients undergoing coronary 
angiography between 
 December 2013 and Febraury 2014 at the 
department of 
Cardiology, RGGGH, Chennai. 
Exclusion criteria Not willing for angiography; allergic to 
contrast 
underlying chronic kidney disease, urinary 
tract infection 
Methods/ Analysis Detailed history and cardiovascular 
examination will be done.  
Routine investigations and details of 
angiography will be  
Noted . 
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Information sheet 
 
• We are conducting a study on the “STRATIFICATION OF CORONARY 
ARTERY MORPHOLOGY IN DIABETIC CAD  PATIENTS WITH 
MICROALBUMINURIA’’at the Department of Cardiology, Rajiv Gandhi 
Govt. General Hospital, Chennai.The purpose of this study is to analysethe  
Angiographic profile of coronary artery disease among diabetics and non 
diabetic patients undergoing angiography during the period December 2013 
to Feb 2014. 
 
• The privacy of the patients in the research will be maintained throughout the 
study. In the event of any publication or presentation resulting from the 
research, no personally identifiable information will be shared. 
 
• Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time. Your decision will not 
result in any loss of benefits to which you are otherwise entitled. 
 
•  The results of the study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may aid in 
the management or treatment. 
 
     Signature of the investigator                     Signature of the participant 
      Date: 
STRATIFICATION OF CORONARY  
ARTERYMORPHOLOGY IN  
DIABETIC CAD  PATIENTS WITH  MICROALBUMINURIA 
 
PROFORMA 
 
 
NAME                                              AGE/SEX 
IP / OP NO.                                           ADDRESS  
 
 
DURATION OF DIABETES ;                           DRUGS TAKEN   +- INSULIN 
HYPERTENSION Y/N 
CAD   ANGINA / MI 
HF 
PVD 
SMOKER 
ALCOHOLIC 
MENSTRUAL STATUS 
FAMILY H/O CAD 
VITALS 
HT                    WT                   BMI                                        WAIST/ HIP RATIO 
CLINICAL FEATURES 
ECHO 
TMT 
LIPID PROFILE 
B.SUGAR                                                    B. UREA                                            S.CREATININE 
 
URINE SPOT ALBUMIN CREATININE RATIO 
 
CAG          SVD 
                 DVD 
                 TVD 
                TYPE OF LESION           A       B      C 
 
 
 
SYNTAX SCORE 
                 LMCA DISEASE 
                MINIMAL CAD 
                NORMAL 
                COLLATERALS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
                                                                     MASTER CHART 
name age sex 
dura  
dm 
hype
r- 
ten 
smo
ker bmi dbp lvsd sbp 
hd
l ldl tgl 
b  
sugar 
micro
alb.  
Mcg/
mg svd dvd 
dathaiyan 62 male 10 y y 23.4 96 
norma
l 164 37 132 177 116 7.5     
nallakannu 64 male 9 y y 25.4 102 
norma
l 160 35 135 159 138 8.5     
thayalnayaki 68 female 12 n n 26.3 90 
norma
l 130 39 142 156 98 5 
y mid 
LAD  
Tandem   
ravichandran 46 male 9 n y 22.3 88 
norma
l 124 40 152 180 124 7.5 
y LAD 
cutoff   
sankaran 65 male 14 y n 23.4 84 
norma
l 130 33 128 210 168 6 y LCx   
sampath 58 male 12 y y 24.3 106 
norma
l 164 37 127 169 142 7   LAD,LCX 
jayasundari 50 female 6 n n 22.5 70
norma
l 132 39 137 162 120 5.5   
barani 59 male 13 n y 20.3 90 mild 150 38 138 190 110 9  y  RCA   
doss 52 male 10 n n 19.6 80 
norma
l 120 38 139 152 116 12     
jaya 50 female 7 n n 23.4 88 mild 122 41 148 179 90 11.5     
kasthri 58 female 6 y n 29.9 86 
norma
l 132 40 148 170 110 6.5   LAD,RCA 
backiam 62 female 8 y n 24.6 80 
norma
l 126 39 147 152 90 7.5   LADRCA 
selvam 56 male 11 y y 22.6 96 
norma
l 146 35 154 164 96 11.5 mid LAD   
kala 59 female 5 y n 25.5 100 
norma
l 150 39 178 180 96 14.5   LADLCX 
kamala 67 female 4 y n 23.5 80 mild 120 38 122 192 120 11   LADLCX 
kalyani 60 female 10 n n 25.4 80 mild 120 40 138 158 124 13     
gayathri 65 female 11 n n 23.5 80 
norma
l 130 39 152 158 98 8.5 mid LAD   
vasu 59 male 9 y y 23 90 
norma
l 130 37 160 172 172 9   LADRCA 
banumathy 63 female 16 y n 24.6 70 
norma
l 120 33 130 182 128 6   LADRCA 
dhanam 61 female 10 y n 25.5 60 
norma
l 120 36 138 158 114 10 
DISTAL 
LAD   
murugesan 69 male 9 y y 24.6 96 
norma
l 146 42 158 158 118 14.5   LADRCA 
raja 53 male 11 n y 25.5 100 
norma
l 150 41 138 174 124 11.5 mid LAD   
nalan 49 male 9 y y 23.6 106
norma
l 164 38 138 182 120 8.5   
kannan 52 male 10 n y 24.4 96 
norma
l 130 39 142 192 182 6.5   LADLCX 
dharani 58 female 6 y n 23.4 80 mlid 120 42 152 178 100 7 y RCA   
kannan k 46 male 12 y y 24.4 70 mild 120 32 142 181 98 7 y RCA   
kamala 52 female 8 y n 23.4 96 
norma
l 166 38 166 172 118 8.5     
dyaneswar 44 male 6 y y 22.3 102 
norma
l 156 37 172 168 124 9   LADRCA 
selvam 68 male 12 y y 24.6 100 mild 176 42 144 174 144 12   RCALCX 
mani 52 male 4 n n 22.2 86 
norma
l 130 36 142 158 86 13.5 y LCX   
koteeswaran 62 male     y 23.4 94 
norma
l 146 38 148 156 98 6.5   LADLCX 
nagammal 58 female     n 22.2 80 
norma
l 120 42 138 140 86 7.5     
lashmi 56 female     n 25.5 84 
norma
l 124 38 148 156 112 7.5     
sarala 65 female   y n 27.5 80 
norma
l 120 36 160 158 100 8.5   LADLCX 
deviammal 69 female     n 24.5 70 
norma
l 110 42 154 140 86 11.5     
rajendiran 72 male   y n 23.5 70 
norma
l 114 34 166 158 88 12   LADRCA 
mohana 61 female     n 26 80 
norma
l 110 42 146 166 110 11.5   LADRCA 
ravichandran 64 male     n 25.5 74 
norma
l 120 34 166 148 88 10.5     
raji 58 female   y n 23.6 68 
norma
l 100 38 148 134 86 6.5   LADRCA 
renuka 57 female     n 22.3 80 
norma
l 116 36 168 144 78 8     
raja 65 male     y 25.5 94 
norma
l 148 38 156 140 88 9.5     
rajeswari 52 female     n 27.6 80 
norma
l 120 38 158 154 100 9     
lakshmi 60 male     y 24.6 102 
norma
l 172 32 168 180 100 6.5     
moovendan 65 male     y 25.9 100 
norma
l 160 38 166 158 88 7.5   LADLCX 
devi 51 female     n 27 80 
norma
l 130 42 148 158 86 8     
rajam 53 female     n 24.4 88 
norma
l 120 42 138 148 80 8   LADRCA 
mary 66 female   y n 23 80 mild 132 40 146 150 84 9.5     
kannan 68 male     n 25.5 84 
norma
l 126 44 138 146 110 8     
rangan 67 male     y 20.4 96 
norma
l 146 36 166 158 102 7   LADRCA 
karthikeyan 61 male   y y 22.3 86 
norma
l 120 38 154 144 78 6.5   LADRCA 
fathima 59 female   y n 24.5 80 
norma
l 120 40 166 146 80 9.5     
raja 64 male     y 20.5 100 
norma
l 146 34 158 158 88 10.5   LADLCX 
sheela 55 female   y n 24.5 86 
norma
l 120 38 166 154 80 11     
peter 66 male   y y 22 88 
norma
l 120 36 166 154 74 12.5     
ranganayagi 52 female     n 20.8 80
norma
l 130 38 144 142 100 9.5   
muhammed 63 male   y n 29.5 76 
norma
l 120 36 166 158 84 9.5     
hameed 69 male   y n 24 80 
norma
l 120 38 148 152 124 7.5     
manickam 72 male     n 23.5 70 
norma
l 110 42 138 144 80 8   LADLCX 
kaliammal 55 female     n 24.3 74 
norma
l 110 40 140 142 98 8.5     
maryammal 52 female     n 22.4 78 
norma
l 118 40 138 152 94 11 mid LAD   
meenakshi 59 female     n 25 70 
norma
l 120 42 136 150 90 11   LADRCA 
                MAU                 
nellaiyappan 62 male   y y 24.6 104 mild 166 34 172 180 124 22.5   LADRCA 
dathaiyan 61 male   y y 25.3 108 
norma
l 170 32 166 162 118 21.5   LADLCX 
nallakannu 61 male   y y 26.4 96 
norma
l 150 30 174 182 114 23.5     
babu 62 male     n 22.4 86 
norma
l 120 36 146 152 142 22   LADRCA 
sabari 60 male   y n 21.5 80 mild 130 40 152 142 90 25.5     
ravichandran 61 male     y 24.3 104 mild 160 38 156 158 86 21.5   LADLCX 
muniswari 57 female     n 26.5 76 
norma
l 110 38 144 152 80 23.5   LADLCX 
rangan 55 male     y 22.4 98 
norma
l 148 36 152 184 98 27   LADRCA 
sivabalan 59 male   y y 21.6 100 mild 150 36 164 174 100 22.5     
ravi 62 male   y n 25.5 104 
norma
l 160 34 172 158 86 21.5   LADRCA 
muniappan 61 male   y y 22.6 80 
norma
l 120 34 164 210 154 24   LADRCA 
vedappan 65 male   y n 24.6 76 mild 110 38 146 152 124 23   LADRCA 
safana 62 female   y n 25.7 70 
norma
l 110 40 146 152 78 21.5     
virudeeswari 63 female   y n 24.8 80 
norma
l 120 38 158 182 114 25.5   LADLCX 
vellammal 60 female   y n 25.4 90 
norma
l 140 36 158 164 110 23   LADRCA 
vetrivelan 58 male     n 23.5 84 
norma
l 120 38 154 146 86 22.5   LADRCA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
